Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Minich

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|June 21, 2011
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapideRalph P Robinson, Jeremy A Bartlett, Peter Bertinato, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2Jeffrey W Corbett, Kevin D Freeman-Cook, Richard Elliott, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethersSubas M Sakya, Hengmiao Cheng, Kristin M Lundy Demello, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analogSubas M Sakya, Kristin M Lundy DeMello, Martha L Minich, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitorsHengmiao Cheng, Kristin M Lundy DeMello, Jin Li, et al.
Journal of Medicinal Chemistry|December 14, 2012
Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119Etzer Darout, Ralph P Robinson, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.
Journal of Medicinal Chemistry|December 27, 2011
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitusJeffrey A Pfefferkorn, Angel Guzman-Perez, John Litchfield, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Bioorganic & Medicinal Chemistry Letters|June 21, 2011
Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapideRalph P Robinson, Jeremy A Bartlett, Peter Bertinato, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2010
Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2Jeffrey W Corbett, Kevin D Freeman-Cook, Richard Elliott, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure-activity relationship studies of 5-alkylethers and 5-thioethersSubas M Sakya, Hengmiao Cheng, Kristin M Lundy Demello, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analogSubas M Sakya, Kristin M Lundy DeMello, Martha L Minich, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitorsHengmiao Cheng, Kristin M Lundy DeMello, Jin Li, et al.
Journal of Medicinal Chemistry|December 14, 2012
Design and synthesis of diazatricyclodecane agonists of the G-protein-coupled receptor 119Etzer Darout, Ralph P Robinson, Kim F McClure, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.
Journal of Medicinal Chemistry|December 27, 2011
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitusJeffrey A Pfefferkorn, Angel Guzman-Perez, John Litchfield, et al.
Pageof 7